Erythrocyte membrane-coated nanogel for combinatorial antivirulence and responsive antimicrobial delivery against Staphylococcus aureus infection

Summary

This study combines toxin neutralization with environment-responsive antibiotic release in a single red-blood-cell membrane-coated nanogel for methicillin-resistant Staphylococcus aureus infection. The nanogel was formed in situ using membrane vesicles as a template, while disulfide cross-links made the polymer network sensitive to reducing intracellular conditions. Outside cells, the red-blood-cell membrane acted as a decoy that absorbed MRSA-associated toxins. Neutralizing those toxins also promoted uptake of bacteria by macrophages. Once the carrier entered a reducing intracellular environment, its disulfide network released antibiotic more rapidly. In macrophages harboring intracellular MRSA, the responsive membrane-coated gel suppressed bacterial growth more effectively than free antibiotic and nonresponsive nanogel controls. The principal result is a staged treatment mechanism: extracellular antivirulence protection facilitates host-cell clearance, followed by triggered antimicrobial delivery where bacteria persist intracellularly. This design is significant because it addresses both secreted virulence factors and protected intracellular organisms. However, the abstract reports cell-based evidence rather than animal treatment outcomes, gives no quantitative release, toxin, uptake, bacterial-killing, cytotoxicity, or sample-size data, and does not establish pharmacokinetics, resistance effects, biodegradation, systemic safety, or efficacy in human infection.